In recent months, we unfortunately had to turn down repeated requests for dissolution tests for which we would have needed the Dissolution USP 4 CE 7smart device. This was neither satisfactory for our customers nor for us. We have taken this situation seriously and ated accordingly:
A brand-new Dissolution USP 4 CE 7smart device will be ready for use from 01 June 2022.
Medical devices, stents, implants, coated lenses, dialysis insert
The flow-through cell method allows us to see differences in formulations that dissolution apparatus 1 and 2 simply do not show. This technique is also widely recommended for poorly soluble, modified / extended release, and low dose products.
Whether you need API screening and characterization, R&D feasibility or QC routine analysis and stability studies (GMP), Rosa Latorre’s team is there to assist you.